Ledger.

Professor, The University of Sydney

Professor Tony Weiss

Coverage

Stories naming Professor Tony Weiss. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Grant

CICADA TURNS 20: How synthetic skin biotech Elastagen changed lives

Anniversary profile of incubator Cicada Innovations' two decades, telling portfolio biotech Elastagen's story: its tropoelastin work, Series A backing, a government grant, and its 2018 sale to Allergan.

Startup Daily Mon 14 Sep 2020 Elastagen Pty LtdAllergan plcBrandon Capital PartnersCicada InnovationsGBS Venture Partners Ltd.NSW HealthPathway to Diversity in STEM ReviewThe University of Sydneythe NSW state governmentRob DanielsSally-Ann WilliamsProfessor Tony Weiss

Also GBS Ventures·GBS Ventures

Series B $14m

Cell Innovation Partners, Japanese venture group, invests in Elastagen as part of a Second Close to the Series B Equity Financing.

Cell Innovation Partners invested A$1 million in Sydney biotech Elastagen within a second close of its A$14 million Series B, with AMOREPACIFIC Ventures, Korea Investment Partners and the Wellcome Trust also joining the round.

GBS Ventures Tue 21 Jun 2016 Elastagen Pty LtdThe University of SydneyAMOREPACIFIC VenturesCell Innovation Partners LimitedKorea Investment PartnersWellcome TrustRobert DanielsProfessor Tony Weiss

Something wrong? Tell us